Concomitant medications experiment in method validation [Bioanalytics]

posted by Obinoscopy  – USA, 2018-05-02 04:05 (1311 d 14:16 ago) – Posting: # 18745
Views: 3,074

Dear Chandru

» We add the concomitant medications to LLOQ of analyte and compare against the calibration standard.

For concomitant medications, you compare the LLOQ (spiked with concomitant medications) with Blank Samples (also spiked with concomitant medications) and calculate the signal to noise ratio (or %interference). Response of interfering peaks at the retention time of the analyte for the blank samples should be less than 20% of the lower limit of quantification for the analyte and 5% for the internal standard.

» Any additional experiment has to be performed to evaluate its effect.

Precision and Accuracy needs to be evaluated for the range of CC standards (spiked with the concomitant medications)

Incurred Sample Reanalysis also give an insight on the effect of concomitant medications.

These are my thoughts.

Regards,

Scopy

Complete thread:

Activity
 Admin contact
21,785 posts in 4,556 threads, 1,547 registered users;
online 8 (0 registered, 8 guests [including 5 identified bots]).
Forum time: Friday 17:22 CET (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5